Martin Brenner - 27 Jul 2023 Form 4 Insider Report for iBio, Inc. (IBIO)

Role: Chief Executive Officer and Chief Scientific Officer
Signature: /s/ Martin Brenner
Issuer symbol: IBIO
Transactions as of: 27 Jul 2023
Net transactions value: -$2,308
Form type: 4
Filing time: 28 Jul 2023, 16:01:20 UTC
Previous filing: 13 Jul 2023
Next filing: 24 Aug 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	IBIO	Common Stock	Sale	$2,290	-4,480	-2.2%	$0.5111	201,911	27 Jul 2023	Direct	F1
transaction	IBIO	Common Stock	Sale	$17.85	-35	-0.02%	$0.5100	201,876	27 Jul 2023	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The sales reported on this Form 4 represent shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units ("RSUs"). The sales were to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and do not represent a discretionary transaction by the Reporting Person. The RSUs represent a contingent right to receive one share of common stock of iBio, Inc. (the "Issuer").

Content

The sales reported on this Form 4 represent shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units ("RSUs"). The sales were to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and do not represent a discretionary transaction by the Reporting Person. The RSUs represent a contingent right to receive one share of common stock of iBio, Inc. (the "Issuer").

Remarks:

Chief Executive Officer and Chief Scientific Officer